Identification of Serum Level of Glutathione Peroxidase 4
NCT06554392 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 85
Last updated 2024-08-15
Summary
* Analysis of the level of glutathione peroxidase 4 (GPX4) in ankylosing spondylitis and axial psoriatic arthritis patients.
* The association of glutathione peroxidase 4 (GPX4) with disease activity and severity in ankylosing spondylitis and axial psoriatic arthritis patients.
Conditions
- Spondyloarthropathy
Interventions
- DIAGNOSTIC_TEST
-
Blood sample
Blood sample from each subject to detect Glutathione Peroxidase 4.
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Marwa Abdelaziz, Prof. · Rheumatology,Rehabilition,Physical therapy Department ,Assiut university
-
Marwa Galal, Ass. Prof. · Rheumatology,Rehabilition,Physical therapy Department ,Assiut university
-
Nesreen Ibrahim, Dr · Rheumatology,Rehabilition,Physical therapy Department ,Assiut university
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2026-09-01
- Completion
- 2027-07-01
More Related Trials
-
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE)
NCT02338999 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus
NCT06857214 ·Status: RECRUITING ·Phase: PHASE1
-
Assessment of Blood Indices in Systemic Lupus Erythematosus
NCT06872086 ·Status: NOT_YET_RECRUITING
-
T Regulatory Cells IN LUPUS NEPHRITIS
NCT06428539 ·Status: NOT_YET_RECRUITING
-
Urinary G3BP as a Novel Biomarker in Lupus Nephritis
NCT06520670 ·Status: NOT_YET_RECRUITING
-
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
NCT06106893 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Association of Serum Interleukin-33 Levels With Clinical Manifestations in Systemic Lupus Erythematosus
NCT07149402 ·Status: NOT_YET_RECRUITING
-
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
NCT06610422 ·Status: NOT_YET_RECRUITING
-
Assessment of CXCL5 Level in SLE Patients and Its Correlation with Disease Activity
NCT06610409 ·Status: NOT_YET_RECRUITING
-
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
NCT07122076 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
NCT06544343 ·Status: RECRUITING ·Phase: NA
-
New Signaling Pathway Targeting Systemic Lupus Erythematosus
NCT03984227 ·Status: UNKNOWN
-
Platelet and Red Blood Cell Volume Indices as Inflammatory Biomarkers in Ankylosing Spondylitis
NCT05997108 ·Status: UNKNOWN
-
Accuracy, Feasibility and Acceptance of CGM Lupus
NCT03296995 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
NCT06394063 ·Status: RECRUITING ·Phase: NA
-
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease
NCT07132112 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 ·Status: UNKNOWN
-
Long-Term Outcomes in SLE at Peking University People's Hospital
NCT07005479 ·Status: RECRUITING
-
Efficacy of Vitamin C Supplementation on Serum TNF-α Levels and Disease Activity in SLE Patients
NCT07071233 ·Status: COMPLETED ·Phase: NA
-
Unmet Needs of Axial Spondyloarthrits in Egyptian Patients
NCT05517031 ·Status: UNKNOWN
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of Telitacicept in Early SLE
NCT05899907 ·Status: UNKNOWN ·Phase: PHASE4
-
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus.
NCT05479071 ·Status: UNKNOWN
-
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
NCT06182969 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus
NCT06842810 ·Status: NOT_YET_RECRUITING